Uterine leiomyoma: influence of the method of surgery on a woman's quality of life
- Authors: Oboskalova T.A.1, Koval M.V.1, Bogdanova A.M.1,2, Sevostyanova O.Y.1, Askerova M.G.1
-
Affiliations:
- Ural State Medical University
- Central City Hospital 7, Yekaterinburg
- Issue: Vol 42, No 2 (2025)
- Pages: 29-37
- Section: Original studies
- Submitted: 29.08.2024
- Published: 27.05.2025
- URL: https://permmedjournal.ru/PMJ/article/view/635504
- DOI: https://doi.org/10.17816/pmj42229-37
- ID: 635504
Cite item
Abstract
Objective. То determine the changes in the quality of life in patients with uterine leiomyoma after various methods of surgical treatment.
Materials and methods. The patients who underwent a planned surgery for uterine leiomyoma at Central City Hospital No. 7 in Yekaterinburg participated in the study. The validated questionnaire SF-36 “Assessment of the Quality of Life” was used; the patients filled it in before and 2 months after the surgery. The respondents were randomized into groups: those who underwent total hysterectomy (n = 20), subtotal hysterectomy (n = 20) or myomectomy (n = 20). The results are presented as median values and standard deviations.
Results. The quality of life of women has improved after the surgical treatment for uterine leiomyoma. The average quality of life indicator increased after subtotal hysterectomy by 13,2 (9,2) %, after myomectomy – by 16,6 (8,1) %, after total – by 21,6 (5,1) %.
Conclusions. Any method of surgery for uterine leiomyomas improves the quality of life of women. After total hysterectomy, the quality of life indicators are higher than after subtotal variant and organ-preserving operations.
Full Text
Introduction
Uterine leiomyoma (uterine fibroid) is the most common type of benign tumor in the female reproductive system. Currently, uterine fibroids are diagnosed in 70 % of gynecological patients. The detection rate of uterine fibroids continues to rise, due to the introduction of more advanced and accessible diagnostic methods [1–3].
The main clinical manifestations of the disease include prolonged and/or heavy uterine bleeding, anemia, abdominal pain syndrome, pelvic organ symptoms, and reproductive dysfunction in the form of infertility and miscarriage [4; 5]. These symptoms negatively affect physical activity, psychological well-being, social and intimate relationships, and overall quality of life [6–8].
Surgical interventions such as uterine curettage, hysteroresectoscopy, myomectomy, uterine amputation or extirpation, uterine artery embolization, and focused ultrasound ablation of fibroids [9–11] are used for the diagnosis and treatment of uterine leiomyoma. The most common procedures are hysterectomy and myomectomy. Organ-preserving techniques remain the unconditional choice for patients but do not prevent tumor recurrence [12]. Radical surgery leads to loss of fertility and affects ovarian blood supply, which may accelerate the onset of menopause [13; 14]. Quite often, the result of hysterectomy is not only the elimination of the disease cause but also the development of complications that reduce patients' quality of life. About 30% of patients develop chronic pelvic pain, while others experience intestinal problems, urinary incontinence, vaginal prolapse, as well as emotional and physiological difficulties in marital relationships [15–17]. The option of surgical treatment with cervix preservation remains debatable, as this approach may subsequently increase the risk of precancerous and cancerous cervical conditions [18].
Quality of life also depends on the surgical approach to the abdominal cavity. With the development of minimally invasive techniques, laparoscopic surgery has become the most common method for treating uterine fibroids due to optimal cosmetic results, faster postoperative recovery, and fewer postoperative complications [19].
The objective of the study is to evaluate changes in the quality of life in patients with uterine leiomyoma before and after different surgical treatment.
Materials and Methods
A prospective observational study was conducted from September 2023 to April 2024 at the gynecological department of City Clinical Hospital No. 7 in Yekaterinburg. Patients with uterine leiomyoma admitted for elective surgical treatment were surveyed before surgery and two months after the intervention. Participants were randomized into three groups: Group 1 – women who underwent total hysterectomy (n = 20); Group 2 – women who underwent subtotal hysterectomy (supracervical uterine amputation) (n = 20); Group 3 – women who underwent myomectomy (n = 20). All surgeries were performed via laparoscopic approach with preservation of uterine adnexa. The study utilized the validated SF-36 Quality of Life Questionnaire. Quality of life was assessed across eight domains of the questionnaire.
1) Physical Functioning (PF) was used to assess physical activity. The scale indicator reflected the amount of daily physical activity not limited by health status;
2) Role-Physical Functioning (RP) characterized the impact of physical problems on routine activities, reflecting the degree to which health limitations affected work performance or daily responsibilities;
3) Bodily Pain (BP) scale allowed evaluation of pain intensity and its effect on normal activities during the past month;
4) General Health (GH) showed current health status, expected treatment outcomes, and resistance to illness;
5) Vitality (VT) scale was designed to measure feelings of full strength and energy;
6) Social Functioning (SF) assessed the level of social activity and satisfaction with communication during the past four weeks;
7) Role-Emotional Functioning (RE) illustrated how emotional state affected work performance and daily responsibilities;
8) Mental Health (MH) characterized mood, presence of depression and/or anxiety, as well as the overall indicator of positive emotions.
The survey results were grouped into two indicators: "physical" (PHs) and "mental" health components (MHs). The "Physical" health component (PHs) takes into account the results of the first four sections of the scale. The " Mental " health component (MHs) includes the results of the subsequent four questionnaire sections. For each scale section, the maximum value is 100 points. These scores can range from 0–100, where 100 represents the best possible quality of life and zero indicates the worst one [20].
The analysis of mean values and standard deviations M (SD) was performed for each scale section before surgical treatment and two months after surgery. Statistical significance was calculated for the sample with n = 20, with a critical t-value of 2.093 according to Student's t-test at an acceptable significance level of p = 0.05. The arithmetic mean and standard deviation - M (SD) were calculated. Statistical data processing was performed using MS Excel 2016.
Results and Discussion
According to the clinical guidelines "Uterine Fibroids," the average age at diagnosis of uterine fibroids is 32–34 years, with peak incidence occurring at the onset of menopause. In our study, the mean age of respondents was 43.38 (3.94) years. All patients reported a history of vaginal or surgical delivery, with an average of 1.6 (0.8) deliveries. A desire to plan pregnancy was expressed by 50 % (10) of patients who subsequently underwent myomectomy and 15 % (3) of women from other groups. The most often indications for surgery in the first group were abnormal uterine bleeding, while the second group primarily had a combination of uterine fibroids with other gynecological pathologies, and the third group showed rapid tumor growth and large fibroid size. The diagnosis was first established on an average of 5.06 (1.12) years prior. However, only 15 % (9) of the 60 respondents received conservative treatment before the surgery. At the same time, some publications indicate stabilization of fibroid size and improved quality of life in patients undergoing hormonal and/or symptomatic treatment [21].
Prior to surgery, women who had undergone total hysterectomy reported lower quality of life scores in the following domains: Role-Physical functioning (RP), Bodily Pain (BP), Social Functioning (SF), and Role-Emotional functioning (RE). These findings likely reflect the clinical characteristics of their tumors and the specific indications for surgical intervention.
Two months postoperatively, the total hysterectomy group demonstrated significant improvements in both physical and mental health components compared to preoperative baseline (Table 1). This positive trend was particularly evident in three physical health domains: Physical Functioning (PF), Bodily Pain (BP), and General Health (GH). Similar improvements were observed for three mental health components: Vitality (VT), Social Functioning (SF), and Mental Health (MH), indicating enhanced social engagement. However, the Role-Emotional (RE) domain, which assesses emotional limitations in work and daily activities, showed no significant changes (Table 1).
Table 1. SF-36 quality of life assessment results for total hysterectomy
Indicator | Before surgery, points | 2 months post-operative, points | t-value | P |
ИМТ | 26.48 (4.55) | 26.48 (4.55) | – | – |
PF | 84.75 (20.74) | 91.5 (17.18) | 2.22 | 0.032* |
RP | 52.5 (44.35) | 70 (41.04) | 2.05 | 0.203 |
BP | 54.45 (30.57) | 72.4 (30.1) | 2.87 | 0.049* |
GH | 61.2 (15.96) | 72.9 (14.03) | 3.99 | 0.018* |
VT | 47.5 (24.09) | 59.5 (22.71) | 2.66 | 0.013* |
SF | 65 (27.98) | 79.38 (25.42) | 2.67 | 0.047* |
RE | 55 (40.86) | 70 (38.84) | 2.02 | 0.241 |
MH | 52.8 (21.78) | 63.8 (19.83) | 2.82 | 0.024* |
PHs | 46.97 (8.78) | 51.8 (7.69) | 2.92 | 0.031* |
MHs | 38.82 (11.52) | 44.68 (11.73) | 2.84 | 0.028* |
Note: *р – statistically significant differences.
While total hysterectomy represents a technically more complex procedure with a longer operative period and potentially higher risks of intra- and postoperative complications – factors that might theoretically predict worse health outcomes [22] – our clinical experience suggests that surgical outcomes depend substantially on the gynecological surgeon's skill level. Notably, in our study cohort, total hysterectomy was associated with a greater quality of life improvements according to the mean SF-36 questionnaire scores two months after surgical treatment compared to the subtotal approach. However, the dynamics across different questionnaire domains differed between the total and subtotal hysterectomy (supracervical uterine amputation) groups.
After subtotal hysterectomy, no significant increases were observed in either the physical or mental component scores of the SF-36 (Table 2). Positive changes were only noted in three domains: general health (GH), role-emotional functioning (RE), and mental health (MH).
Table 2. SF-36 quality of life assessment results for subtotal hysterectomy
Indicator | Before Surgery, points | 2 Months Post-Op, points | t-value | P |
ИМТ | 25.89 (4.89) | 25.89 (4.89) | – | – |
PF | 81.75 (24.08) | 85.25 (21.06) | 0.54 | 0.627 |
RP | 62.5 (44.79) | 81.25 (36.16) | 0.61 | 0.153 |
BP | 67.3 (28.1) | 74.05 (25.24) | 1.13 | 0.133 |
GH | 60 (16.09) | 68.25 (17.92) | 2.36 | 0.042* |
VT | 45.25 (28.4) | 55.5 (30.34) | 1.82 | 0.270 |
SF | 80 (20.84) | 83.75 (24.37) | 0.77 | 0.062 |
RE | 68.33 (43.12) | 85 (33.29) | 2.16 | 0.036* |
MH | 52.6 (22.03) | 56.4 (28.84) | 3.96 | 0.045* |
PHs | 48.2 (8.51) | 51.42 (5.57) | 1.91 | 0.165 |
MHs | 41.48 (10.49) | 44.92 (12.79) | 1.33 | 0.357 |
Note: *р – Statistically significant differences.
Some literature sources report advantages of subtotal hysterectomy over total hysterectomy in terms of lower risk of subsequent prolapse and improved sexual function [23]. It should be noted that subtotal hysterectomy is not indicated in all clinical cases, but only when there are no cervical diseases or deep infiltrative endometriosis. Patients must be counseled about the need for regular follow-up with a gynecologist due to oncological vigilance considerations.
The lack of significant changes in pain scores after subtotal hysterectomy requires additional analysis to refine surgical indications, optimize early and late postoperative management, and improve rehabilitation strategies. The observed differences may be explained by the fact that women undergoing total hysterectomy had tumors that significantly impacted their health status, social and role functioning to such an extent that organ removal was perceived as relief from suffering and a return to a healthy, full-quality life.
Before surgery, patients undergoing myomectomy had the lowest scores in the mental health component (MHs) of quality of life. Two months after surgery, this indicator showed a statistically significant rise along with measures of physical, social, and role functioning. This positive change likely reflects not only the relief from uterine fibroid symptoms but also the resolution of anxiety regarding reproductive plans in this patient group (Table 3).
Table 3. SF-36 quality of life assessment results for myomectomy
Indicator | Before Surgery, points | 2 Months Post-Op, points | t-value | P |
ИМТ | 24.28 (4.25) | 24.28 (2.89) | – | – |
PF | 82.25 (22.34) | 89.44 (14.81) | 2.05 | 0.562 |
RP | 60.5 (34.32) | 84.5 (54.39) | 0.75 | 0.062 |
BP | 80.35 (40.54) | 82.3 (26.2) | 2.41 | 0.047* |
GH | 65.2 (25.36) | 68 (46.19) | 2.28 | 0.045* |
VT | 57.5 (21.09) | 60.25 (38.4) | 2.33 | 0.045* |
SF | 75 (27.98) | 80 (20.84) | 2.06 | 0.082 |
RE | 59 (40.86) | 68.33 (43.12) | 0.66 | 0.066 |
MH | 52.8 (21.38) | 66.6 (42.03) | 0.03 | 0.133 |
PHs | 52.97 (8.78) | 57.2 (8.51) | 2.61 | 0.038* |
MHs | 35.32 (41.52) | 44.38 (25.49) | 0.83 | 0.165 |
Note: *p – Statistically significant differences.
Uterine leiomyoma remains one of the most common indications for surgical treatment. The extent and method of surgical intervention should be carefully justified in each individual case. Our results demonstrate improved quality of life scores two months after surgery compared to preoperative values. Following total hysterectomy, quality of life indicators increased by an average of 21.6 % (5.1), after myomectomy by 16.6 % (1.8), and after subtotal hysterectomy by 13.2 % (9.2).
Conclusions
- Surgical treatment of uterine leiomyoma improves quality of life in women.
- After total hysterectomy, quality of life indicators are higher than after organ-preserving methods (myomectomy) and subtotal hysterectomy.
- Myomectomy is the method of choice for patients planning future pregnancy.
- Subtotal hysterectomy requires more thorough evaluation of postoperative pain syndrome, individualized management of both early and late postoperative periods, and mandatory implementation of rehabilitation measures.
About the authors
T. A. Oboskalova
Ural State Medical University
Email: marinakoval1203@gmail.com
ORCID iD: 0000-0003-0711-7896
DSc (Medicine), Professor, Head of the Department of Obstetrics and Gynecology with a Course in Medical Genetics
Russian Federation, YekaterinburgM. V. Koval
Ural State Medical University
Author for correspondence.
Email: marinakoval1203@gmail.com
ORCID iD: 0000-0003-1321-6583
PhD (Medicine), Associate Professor the Department of Obstetrics and Gynecology with a Course in Medical Genetics
Russian Federation, YekaterinburgA. M. Bogdanova
Ural State Medical University; Central City Hospital 7, Yekaterinburg
Email: marinakoval1203@gmail.com
ORCID iD: 0009-0006-2819-2659
PhD (Medicine), Assistant of the Department of Topographic Anatomy and Operative Surgery
Russian Federation, Yekaterinburg; YekaterinburgO. Yu. Sevostyanova
Ural State Medical University
Email: marinakoval1203@gmail.com
ORCID iD: 0000-0002-0828-0479
DSc (Medicine), Professor of the Department of Obstetrics and Gynecology with a Course in Medical Genetics
Russian Federation, YekaterinburgM. G. Askerova
Ural State Medical University
Email: marinakoval1203@gmail.com
ORCID iD: 0000-0002-0705-9748
PhD (Medicine), Associate Professor of the Department of Obstetrics and Gynecology with a Course in Medical Genetics
Russian Federation, YekaterinburgReferences
- Uterine fibroids. Clinical recommendations. Moscow 2022; 35 (in Russian).
- Sevostyanova O.Yu., Koval M.V., Chumarnaya T.V. et al. Аnalysis of the incidence of uterine fibroid in Yekaterinburg. Opukholi zhenskoy reproduktivnoy systemy = Tumors of Female Reproductive System 2024; 20 (2): 99–104. doi: 10.17650/1994-4098-2024-20-2-00-00 (in Russian).
- Wilson L.F., Moss K.M., Doust J., Farquhar C.M., Mishra G.D. First Australian estimates of incidence and prevalence of uterine fibroids: a data linkage cohort study 2000–2022. Human Reproduction 2024; 00 (0): 1–10. doi: 10.1093/humrep/deae162
- Alejnikova E.Yu., Solov'eva A.V. Mioma matki: sovremennye metodiki, preimushchestva i oslozhneniya. RUDN Journal of Medicine. Seriya: Medicina 2023; 27 (1); 57–64. doi: 10.22363/2313-0245-2023-27-1-57-64 (in Russian).
- Navarro A., Bariani M.V., Yang Q., Al-Hendy A. Understanding the Impact of Uterine Fibroids on Human Endometrium Function. Front Cell Dev Biol. 2021; 25 (9): 633180. doi: 10.3389/fcell.2021.633180
- Jing Zeng, Jing Wang, Min Wang, Xiaoli Wang. A comparative study on myomectomy and total hysterectomy in the treatment of perimenopausal uterine fibroids. European Journal of Gynaecological Oncology 2024; 45 (2): 141–146. doi: 10.22514/ejgo.2024.036
- Han X., Wu T.Q., Bian Y., Chen L., Feng X. Psychological distress and uterine fibroids: a bidirectional two-sample mendelian randomization study. BMC Womens Health 2024; 24 (1): 351. doi: 10.1186/s12905-024-03196-8
- Firmeza M.A., Vasconcelos C.T.M., Vasconcelos Neto J.A., Brito LGO, Alves F.M., Oliveira N.M.V. The effects of hysterectomy on urinary and sexual functions of women with cervical cancer: A systematic review. Rev Bras Ginecol Obstet. 2022; 44 (8): 790–796. doi: 10.1055/s-0042-1748972
- Mina S. Makary, Kylie Zane, Gloria L. Hwang, Charles Y. Kim, Osmanuddin Ahmed еt all. ACR Appropriateness Criteria® management of uterine fibroids: 2023 update. Journal of the American College of Radiology 2024; 21 (6): 203–218. doi: 10.1016/j.jacr.2024.02.022
- Sadyhova E.E., Bezhenar' V.F., Arakelyan B.V. Analysis of the results of surgical organ preservation treatment of uterine myoma in urgent gynecology in patients with heavy anemia. Health and Education Millennium 2019; 21 (3): 37–42. doi: 10.26787/nydha-2226-7425-2019-21-3 (in Russian).
- Sadykhova E.E., Bezhenar V.F., Arakelyan B.V. et al. Opportunities for the use of X-ray endosurgical hemostasis in complex treatment of uterine myoma in patients with severe anemia. Ural Medical Journal 2019; 3 (171): 59–63. doi: 10.25694/URMJ.2019.03.23 (in Russian).
- Podzolkova N.M., Korennaya V.V., Koloda Yu.A., Kuznetsov R.E., Ignatchenko O.Yu. Functional outcomes of myomectomy. Russian Journal of Human Reproduction 2020; 26 (3): 31–38. doi: 10.17116/repro20202603131 (in Russian).
- Yang Q., Ciebiera M., Bariani M.V., Ali M., Elkafas H., Boyer T.G., Al-Hendy A. Comprehensive review of uterine fibroids: Developmental origin, pathogenesis, and treatment. Endocr Rev. 2022; 43 (4): 678–719. doi: 10.1210/endrev/bnab039
- Sobel M., Hobson S., Chan C. Uterine fibroids in pregnancy. CMAJ. 2022; 194 (22): E775. doi: 10.1503/cmaj.211530
- Solopova A.G., Blinov D.V., Begovich E., Sandzhieva L.N., Demyanov S.V., Demyanov G.V. Neurological disorders after hysterectomy: from pathogenesis to clinical manifestations. Epilepsy and paroxysmal conditions 2022; 14 (1): 54–64. doi: 10.17749/2077-8333/ epi.par.con.2022.115 (in Russian).
- Tetelyutina F.K., Korotkova M.N., Sushencova T.V., Ahmed'yanova R.D., Vinohodova E.M. Women's life quality after surgical treatment of uterine fibroids. Medical Newsletter of Vyatka 2020; 3 (67): 39–45. doi: 10.24411/2220-7880-2020-10104 (in Russian).
- Xu W., Chen W., Chen J., Hu L., Su X., Nie Y., Shi Q. Adaptability and clinical applicability of UFS-QoL in Chinese women with uterine fibroid. BMC Womens Health 2022; 22 (1): 372. doi: 10.1186/s12905-022-01963-z
- Karanasheva A.K., Dobrokhotova Y.E. Cervical diseases after subtotal hysterectomy (modern aspects of diagnosis and tactics of management). Gynecology 2021; 23 (6): 504–508. doi: 10.26442/20795696.2021.6.201131 (in Russian).
- Sinha Rooma, Swarnasree G., Rupa B., Madhumathi S. Laparoscopic hysterectomy for large uteri: Outcomes and techniques. Journal of Minimal Access Surgery 2019. 15 (1): 8–13. doi: 10.4103/jmas.JMAS_205_17
- Jenkinson C., Coulter A., Wright L. Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. BMJ. 1993; 306 (6890): 1437–40. doi: 10.1136/bmj.306.6890.1437
- Vannuccini S., Petraglia F., Carmona F., Calaf J., Chapron C. The modern management of uterine fibroids-related abnormal uterine bleeding. Fertil Steril. 2024; 122 (1): 20–30. doi: 10.1016/j.fertnstert.2024.04.041
- Mavrova R., Radosa J.C., Wagenpfeil G., Hamza A., Solomayer E.F., Juhasz-Böss I. Learning curves for laparoscopic hysterectomy after implementation of minimally invasive surgery. Int J Gynaecol Obstet. 2016; 134 (2): 225–30. doi: 10.1016/j.ijgo.2016.01.017
- Vysotskiy M.M., Bejenar' V.F., Ovakimyan M.A. Total or subtotal hysterectomy: time to unveil myths? Endoscopic Surgery 2016; 22 (6): 52‑56. doi: 10.17116/endoskop201622652-56 (in Russian).
Supplementary files

